Whalegun
Home

Ultragenyx Pharmaceutical RARE paid Mehlman Consulting $50K for lobbying in Q3 2024 · Budget, Health Issues

Trade details

Type
Lobbying report
Amount
$50,000
Quarter
Q3 2024
Stock
Ultragenyx Pharmaceutical RARE
Client
Ultragenyx Pharmaceutical
Reported
24/10/18

$380K on lobbying this year

What else happened in Ultragenyx Pharmaceutical around then

Filed or reported within 30 days of the trade day · 24/08/31~24/10/30

Ultragenyx Pharmaceutical's other lobbying reports

Ultragenyx Pharmaceutical RARE paid Mehlman Consulting $50K for lobbying in Q3 2024 · Budget, Health Issues | Whalegun